U.S. markets open in 6 hours 14 minutes
  • S&P Futures

    3,851.50
    +42.25 (+1.11%)
     
  • Dow Futures

    31,223.00
    +311.00 (+1.01%)
     
  • Nasdaq Futures

    13,103.00
    +192.00 (+1.49%)
     
  • Russell 2000 Futures

    2,242.10
    +42.90 (+1.95%)
     
  • Crude Oil

    62.67
    +1.17 (+1.90%)
     
  • Gold

    1,751.90
    +23.10 (+1.34%)
     
  • Silver

    27.02
    +0.58 (+2.19%)
     
  • EUR/USD

    1.2074
    -0.0013 (-0.11%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3962
    +0.0040 (+0.29%)
     
  • USD/JPY

    106.6000
    +0.0980 (+0.09%)
     
  • BTC-USD

    46,347.57
    +1,838.72 (+4.13%)
     
  • CMC Crypto 200

    926.37
    -6.76 (-0.72%)
     
  • FTSE 100

    6,566.50
    +83.07 (+1.28%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020

  • Oops!
    Something went wrong.
    Please try again later.
Travere Therapeutics, Inc.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that the Company will host a virtual R&D Day on Wednesday, December 9, 2020 at 12:00 p.m. ET to review the Company’s key pipeline programs. The event will feature presentations from external experts and the Travere Therapeutics senior management team.

Presenters:

  • Jonathan Hogan, M.D., assistant professor of medicine at the Perelman School of Medicine, University of Pennsylvania, & clinical director, Penn Glomerular Center

  • Jonathan Barratt, Ph.D., FRCP, Mayer professor of renal medicine at the University of Leicester & John Walls Renal Unit, Leicester

  • Eric Dube, Ph.D., chief executive officer at Travere Therapeutics

  • Noah Rosenberg, M.D., chief medical officer at Travere Therapeutics

  • William Rote, Ph.D., senior vice president of research and development at Travere Therapeutics

  • Peter Heerma, chief commercial officer at Travere Therapeutics

Virtual R&D Day Information:

  • Date: Wednesday, December 9, 2020

  • Time: 12:00 p.m. ET (9:00 a.m. PT)

  • Live webcast: Travere.com in the “Events & Presentations” section of the “Investors and Media” Page

A replay of the webcast will be available at https://ir.travere.com/events-presentations and will be accessible for up to 60 days.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com